Attached files

file filename
EX-10.22 - FORM OF STOCK OPTION AGREEMENT - Endo International plcex1022formofstockoptionagre.htm
EX-32.1 - CEO SECTION 906 CERTIFICATION - Endo International plcex3213312016ceo906cert.htm
EX-10.5.2 - NORAMCO 4TH AMENDMENT TO SUPPLY AGREEMENT - Endo International plcex1052noramco4thamendmentto.htm
EX-10.24 - FORM OF PERFORMANCE AWARD AGREEMENT - Endo International plcex1024formofperformanceawar.htm
EX-10.35 - FORM OF INDEMNIFICATION AGREEMENT - Endo International plcex1035endointernationalplc.htm
EX-32.2 - CFO SECTION 906 CERTIFICATION - Endo International plcex3223312016cfo906cert.htm
EX-10.28.1 - NOVARTIS SANDOZ ENDO LETTER AGREEMENT - Endo International plcex10281novartissandozendo.htm
EX-31.2 - CFO SECTION 302 CERTIFICATION - Endo International plcex3123312016cfo302cert.htm
EX-10.23 - FORM OF STOCK AWARD AGREEMENT - Endo International plcex1023formofstockawardagree.htm
EX-10.5.1 - NORAMCO 3RD AMENDMENT TO SUPPLY AGREEMENT - Endo International plcex1051noramco3rdamendmentto.htm
10-Q - 10-Q - Endo International plcendp-3312016x10q.htm
EX-10.5.3 - NORAMCO 5TH AMENDMENT TO SUPPLY AGREEMENT - Endo International plcex1053noramco5thamendmentt.htm
Exhibit 31.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER
PURSUANT TO SECTION 302 OF
THE SARBANES-OXLEY ACT OF 2002
I, Rajiv De Silva, certify that:
1. I have reviewed this quarterly report on Form 10-Q of Endo International plc;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s Board of Directors (or persons performing the equivalent functions):
a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
 
 
/S/ RAJIV DE SILVA
Rajiv De Silva
President and Chief Executive Officer
(Principal Executive Officer)
 
 
Date:
May 6, 2016